Adial Pharmaceuticals, Inc · NASDAQ:ADIL
Coastlands Capital LP reported a 9.98% stake in Adial Pharmaceuticals, Inc (Schedule 13G)
Event Jun 17, 2026 · Filed Jun 24, 2026
Coastlands Capital LP reported a 9.98% stake in Adial Pharmaceuticals, Inc, 262,167 shares, as a passive investor on Jun 17, 2026. Filed Jun 24, 2026 (Schedule 13G).
- Stake
- 9.98%
- Shares
- 262,167
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Coastlands Capital LP | 9.98% | 262,167 |
| Coastlands Capital Partners LP | 9.98% | 262,167 |
| Coastlands Capital GP LLC | 9.98% | 262,167 |
| Coastlands Capital LLC | 9.98% | 262,167 |
| Matthew D. Perry | 9.98% | 262,167 |
Source
Related
- Adial Pharmaceuticals, Inc
- Coastlands Capital LP
- Adial Pharmaceuticals, Inc shareholders
- Schedule 13G/A · Coastlands Capital LP · Jul 1, 2026
- Form 4 · Coastlands Capital LP · Jul 16, 2026
- Form 4 · Coastlands Capital LP · Jul 13, 2026
- Form 4 · Coastlands Capital LP · Jul 1, 2026
- Form 4 · Davidson Matt · Jun 16, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026